Serum potassium concentrations following succinylcholine in patients undergoing beta-adrenoceptor blocking therapy.
Efflux of serum potassium following succinylcholine was compared in surgical patients undergoing low-dose, long-term beta 1-adrenoceptor or beta 1,2-adrenoceptor blocking therapy and in those receiving neither of these therapies. There were no significant differences in serum potassium concentration prior to, and over a study period of, 2 hours following succinylcholine administration among the three groups of patients.